Evidence map›Paper›PMID 37861334›Full record

ArticleJournal of virology2023

Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity.

Sahil Kumar, Rathina Delipan, Debajyoti Chakraborty, Kawkab Kanjo, Randhir Singh, Nittu Singh, Samreen Siddiqui, Akansha Tyagi, Vinitaa Jha, Krishan G Thakur and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteins.Computational and structural biotechnology journal · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Sahil Kumar *CSIR-Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR) , Chandigarh, India.
Rathina Delipan *CSIR-Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR) , Chandigarh, India.
Debajyoti ChakrabortyMolecular Biophysics Unit (MBU), Indian Institute of Science , Bangalore, India.
Kawkab KanjoMolecular Biophysics Unit (MBU), Indian Institute of Science , Bangalore, India.
Randhir SinghMynvax Pvt. Ltd. , Bangalore, India.
Nittu SinghCSIR-Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR) , Chandigarh, India.
Samreen SiddiquiMax Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare , Delhi, India.
Akansha TyagiMax Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare , Delhi, India.
Vinitaa JhaMax Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare , Delhi, India.
Krishan G ThakurCSIR-Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR) , Chandigarh, India.
Rajesh PandeyCSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) , Delhi, India.ORCID 0000-0002-4404-8327
Raghavan VaradarajanMolecular Biophysics Unit (MBU), Indian Institute of Science , Bangalore, India.
Rajesh P RingeCSIR-Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR) , Chandigarh, India.ORCID 0000-0002-6068-4163
Institute of Microbial Technology · INIndian Institute of Science Bangalore · INMax Super Speciality Hospital · INInstitute of Genomics and Integrative Biology · IN

Funding

Council of Scientific and Industrial Research, India (CSIR)CSIR-Institute of Genomics and Integrative Biology MLP-2005DST | Science and Engineering Research Board (SERB) IPA/2020/000168Fondation Botnar (Botnar Foundation) CLP-0031
6 · The paper itself

Abstract

importanceThe Omicron subvariants have substantially evaded host-neutralizing antibodies and adopted an endosomal route of entry. The virus has acquired several mutations in the receptor binding domain and N-terminal domain of S1 subunit, but remarkably, also incorporated mutations in S2 which are fixed in Omicron sub-lineage. Here, we found that the mutations in the S2 subunit affect the structural and biological properties such as neutralization escape, entry route, fusogenicity, and protease requirement.

Indexed as

COVID-19SARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralEndopeptidasesHumansMolecular ConformationMutationPeptide HydrolasesAntibodies, NeutralizingAntibodies, ViralEndopeptidasesPeptide HydrolasesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2neutralizing antibodiesOmicronSARS-CoV-2spike conformationspike proteinvirus entry

Identifiers

PMID37861334
PMCPMC10688319
OpenAlexW4387798576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.